{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T20:38:09Z","timestamp":1783456689569,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1067\/moe.2001.118902","type":"journal-article","created":{"date-parts":[[2002,8,24]],"date-time":"2002-08-24T18:14:26Z","timestamp":1030212866000},"page":"623-628","source":"Crossref","is-referenced-by-count":117,"title":["The effect of antiretroviral therapy on the prevalence of oral manifestations in HIV-infected patients: A UK study"],"prefix":"10.1067","volume":"92","author":[{"given":"Anwar R.","family":"Tappuni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry J.P.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/moe.2001.118902_bib1","first-page":"1","volume":"11","year":"2001","journal-title":"CDR Wkly"},{"key":"10.1067\/moe.2001.118902_bib2","first-page":"273","volume":"10","year":"2000","journal-title":"CDR Wkly"},{"key":"10.1067\/moe.2001.118902_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/jama.1997.03540260059037","article-title":"HIV-1 protease inhibitors. A review for clinicians","volume":"277","author":"Deeks","year":"1997","journal-title":"JAMA"},{"key":"10.1067\/moe.2001.118902_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198707233170401","article-title":"The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial","volume":"317","author":"Fischl","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1067\/moe.2001.118902_bib5","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/0140-6736(93)91109-Y","article-title":"Immediate versus deferred zidovudine","volume":"341","author":"Peto","year":"1993","journal-title":"Lancet"},{"key":"10.1067\/moe.2001.118902_bib6","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(94)90006-X","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1067\/moe.2001.118902_bib7","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(97)04161-5","article-title":"Randomised placebo-controlled trial of ritonavir in advanced HIV-1 disease. The Advanced HIV Disease Ritonavir Study Group","volume":"351","author":"Cameron","year":"1998","journal-title":"Lancet"},{"key":"10.1067\/moe.2001.118902_bib8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1056\/NEJM199803263381310","article-title":"Progress and problems in the fight against AIDS","volume":"338","author":"Hirschel","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/moe.2001.118902_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0140-6736(96)05387-1","article-title":"A randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals","volume":"348","author":"Delta Coordinating Committee","year":"1996","journal-title":"Lancet"},{"key":"10.1067\/moe.2001.118902_bib10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJM199610103351501","article-title":"A trial comparing nucleoside monotherapy with combination therapy in HIV-infected adults with CD4 cell counts from 200 to 500 per cubic millimeter","volume":"335","author":"Hammer","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1067\/moe.2001.118902_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM199610103351503","article-title":"Zidovudine alone or in combination with didanosine or zalcitabine in HIV-infected patients with the acquired immunodeficiency syndrome or fewer than 200 CD4 cells per cubic millimeter","volume":"335","author":"Saravolatz","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1067\/moe.2001.118902_bib12","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0140-6736(96)12073-0","article-title":"British HIV Association guidelines for antiretroviral treatment of HIV seropositive individuals","volume":"349","author":"BHIVA Guidelines Co-ordinating Committee","year":"1997","journal-title":"Lancet"},{"key":"10.1067\/moe.2001.118902_bib13","series-title":"Antiviral drugs\u2014Human immunodeficiency virus. British National Formulary","author":"Joint Formulary Committee","year":"2000"},{"key":"10.1067\/moe.2001.118902_bib14","first-page":"38","article-title":"Drug cocktails fight HIV","author":"Gopinath","year":"1997","journal-title":"Chemistry in Britain"},{"key":"10.1067\/moe.2001.118902_bib15","first-page":"1","article-title":"Advances in HIV\/AIDS therapy","volume":"45","author":"Johnson","year":"2000","journal-title":"Adv Intern Med"},{"key":"10.1067\/moe.2001.118902_bib16","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S1079-2104(00)70092-8","article-title":"Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy","volume":"89","author":"Patton","year":"2000","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1067\/moe.2001.118902_bib17","doi-asserted-by":"crossref","first-page":"187","DOI":"10.14219\/jada.archive.1986.0321","article-title":"Oral findings in people with or at high risk for AIDS: a study of 375 homosexual males","volume":"112","author":"Silverman","year":"1986","journal-title":"J Am Dent Assoc"},{"key":"10.1067\/moe.2001.118902_bib18","first-page":"225","article-title":"Oro-facial manifestations of HIV infections","volume":"38","author":"Vanakul","year":"1998","journal-title":"J Dent Assoc Thai"},{"key":"10.1067\/moe.2001.118902_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/0030-4220(92)90185-S","article-title":"Oral manifestations of HIV infection. Definitions, diagnostic criteria, and principles of therapy. The U.S.A. Oral AIDS Collaborative Group","volume":"73","author":"Greenspan","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1067\/moe.2001.118902_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0714.1993.tb01074.x","volume":"22","year":"1993","journal-title":"J Oral Pathol Med"},{"key":"10.1067\/moe.2001.118902_bib21","first-page":"256","article-title":"CDSC\u2014Further increase in prevalent diagnosed HIV infections in the United Kingdom in England, Wales, or Northern Ireland","volume":"10","author":"Anonymous","year":"2000","journal-title":"Commun Dis Rep CDR Wkly"},{"key":"10.1067\/moe.2001.118902_bib22","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1067\/moe.2001.118902_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1601-0825.1996.tb00223.x","article-title":"Aetiological factors for oral manifestations of HIV","volume":"2","author":"Palmer","year":"1996","journal-title":"Oral Dis"},{"key":"10.1067\/moe.2001.118902_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0030-4220(92)90123-8","article-title":"Correlation of oral disease with the Walter Reed staging scheme for HIV-1-seropositive patients","volume":"73","author":"Thompson","year":"1992","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1067\/moe.2001.118902_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0030-4220(94)90195-3","article-title":"Oral manifestations associated with HIV-related disease as markers for immune suppression and AIDS","volume":"77","author":"Glick","year":"1994","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1067\/moe.2001.118902_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1001\/jama.279.1.35","article-title":"Prognostic indicators for AIDS and infectious disease death in HIV-infected injection drug users: plasma viral load and CD4+ cell count","volume":"279","author":"Vlahov","year":"1998","journal-title":"JAMA"},{"key":"10.1067\/moe.2001.118902_bib27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1600-0714.1999.tb02019.x","article-title":"HIV infection: oral lesions, CD4+ cell count and viral load in an Italian study population","volume":"28","author":"Margiotta","year":"1999","journal-title":"J Oral Pathol Med"},{"key":"10.1067\/moe.2001.118902_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1600-0714.1989.tb00731.x","article-title":"Oral manifestations of HIV infection in 75 Dutch patients","volume":"18","author":"Schulten","year":"1989","journal-title":"J Oral Pathol Med"},{"key":"10.1067\/moe.2001.118902_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.1992.tb00994.x","article-title":"Oral signs and symptoms in 160 Greek HIV-infected patients","volume":"21","author":"Laskaris","year":"1992","journal-title":"J Oral Pathol Med"},{"key":"10.1067\/moe.2001.118902_bib30","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1111\/j.1601-0825.1997.tb00371.x","article-title":"Oral lesions of HIV and AIDS in Asia: an overview","volume":"3","author":"Anil","year":"1997","journal-title":"Oral Dis"},{"key":"10.1067\/moe.2001.118902_bib31","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1601-0825.1998.tb00274.x","article-title":"Oral manifestations of HIV in a southeast USA population","volume":"4","author":"Patton","year":"1998","journal-title":"Oral Dis"},{"key":"10.1067\/moe.2001.118902_bib32","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1601-0825.2000.tb00137.x","article-title":"Prevalence and incidence of oral lesions\u2014the changing scene","volume":"6","author":"Eyeson","year":"2000","journal-title":"Oral Dis"},{"key":"10.1067\/moe.2001.118902_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1034\/j.1600-0714.2000.290708.x","article-title":"Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy","volume":"29","author":"Schmidt-Westhausen","year":"2000","journal-title":"J Oral Pathol Med"},{"key":"10.1067\/moe.2001.118902_bib34","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1079-2104(99)70242-8","article-title":"Frequency of oropharyngeal candidiasis in HIV-infected patients on protease inhibitor therapy","volume":"87","author":"Diz Dios","year":"1999","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1067\/moe.2001.118902_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00126334-199905010-00003","article-title":"Role of protease inhibitors in preventing recurrent oral candidosis in patients with HIV infection: a prospective case-control study","volume":"21","author":"Cauda","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1067\/moe.2001.118902_bib36","first-page":"265","volume":"10","year":"2000","journal-title":"CDR Wkly"},{"key":"10.1067\/moe.2001.118902_bib37","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1046\/j.0909-8836.1998.eos106601.x","article-title":"Salivary defence factor concentrations in relation to oral and general parameters in HIV-positive patients","volume":"106","author":"Grimoud","year":"1998","journal-title":"Eur J Oral Sci"},{"key":"10.1067\/moe.2001.118902_bib38","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1600-0714.1990.tb00790.x","article-title":"Epidemiology, clinical features and prognostic value of HIV-1\u2013 related oral lesions","volume":"19","author":"Moniaci","year":"1990","journal-title":"J Oral Pathol Med"},{"key":"10.1067\/moe.2001.118902_bib39","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S1079-2104(96)80352-0","article-title":"Oral lesions as markers of severe immunosuppression in HIV-infected homosexual men and injection drug users","volume":"82","author":"Begg","year":"1996","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210401759525?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079210401759525?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T09:25:48Z","timestamp":1557393948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079210401759525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S1079210401759525"],"URL":"https:\/\/doi.org\/10.1067\/moe.2001.118902","relation":{},"ISSN":["1079-2104"],"issn-type":[{"value":"1079-2104","type":"print"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}